Deborah Berg

Statistics

Publications

Citations

6.2K

H-Index

Active since

1953

Affiliations

Millennium Engineering and Integration (United States)(Current)

Dana-Farber Cancer Institute

Takeda (United States)

Mayo Clinic in Arizona

Emory University

Deborah Berg is an author at Millennium Engineering and Integration (United States) specializing in medicine, pharmacology, and hematologic malignancy therapy.

Publications per year

1953–2025

Publications

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Robert J. Mayer, Roger B. Davis, Charles A. Schiffer et al. · New England Journal of Medicine · 1994 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

Clara D. Bloomfield, David Lawrence, John C. Byrd et al. · PubMed · 1998 · 696 citations

Medicine, Oncology, Pharmacology +15

Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

Richard M. Stone, Deborah Berg, Stephen L. George et al. · New England Journal of Medicine · 1995 · 455 citations · Full text

Medicine, Hematology, Oncology +14

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study

Shaji Kumar, Jesús G. Berdeja, Rubén Niesvizky et al. · The Lancet Oncology · 2014 · 265 citations

Medicine, Oncology, Pharmacology +14

1–5 of 47